Hantao Zhang

Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

LncRNA ELFN1-AS1 maintains the stemness of colorectal cancer by preventing ubiquitinated degradation of the hnRNPA1 protein.

LncRNA ELFN1-AS1 maintains the stemness of colorectal cancer by preventing ubiquitinated degradation of the hnRNPA1 protein.

Journal: Cellular and molecular life sciences : CMLS

Published: February 26, 2025

Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer.

Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer.

Journal: Cancer biology & medicine

Published: January 02, 2024

A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity.

A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity.

Journal: Oncoimmunology

Published: October 03, 2022

Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.

Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.

Journal: PLoS genetics

Published: April 27, 2020

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.

Journal: Theranostics

Published: February 27, 2020

Corrigendum to: Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.

Corrigendum to: Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.

Journal: Carcinogenesis

Published: February 11, 2020

Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.

Temporal DNA methylation pattern and targeted therapy in colitis-associated cancer.

Journal: Carcinogenesis

Published: August 26, 2019

SARI suppresses colitis-associated cancer development by maintaining MCP-1-mediated tumour-associated macrophage recruitment.

SARI suppresses colitis-associated cancer development by maintaining MCP-1-mediated tumour-associated macrophage recruitment.

Journal: Journal of cellular and molecular medicine

Published: June 20, 2019

Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy.

Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 19, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026